(3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide

C55H95N11O10 — CID 160595542

IUPAC(3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide
SMILESCCCCCCC[C@@H](O)CC(=O)N[C@H](CCN)C(=O)C[C@H]1CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)CC(=O)[C@H](CCCCN)NC1=O
InChIInChI=1S/C55H95N11O10/c1-6-7-8-9-13-18-40(67)34-49(70)61-42(20-25-57)47(68)32-38-23-28-60-52(73)45(29-35(2)3)66-54(75)44(22-27-59)63-53(74)43(21-26-58)64-55(76)46(30-36(4)5)65-51(72)39(31-37-16-11-10-12-17-37)33-48(69)41(62-50(38)71)19-14-15-24-56/h10-12,16-17,35-36,38-46,67H,6-9,13-15,18-34,56-59H2,1-5H3,(H,60,73)(H,61,70)(H,62,71)(H,63,74)(H,64,76)(H,65,72)(H,66,75)/t38-,39+,40-,41+,42-,43+,44+,45+,46+/m1/s1
InChIKeyRDOSPIXDRZEZDQ-SYMXYNERSA-N
MW1070.43 g/mol
LogP1.19
Rot. Bonds28

About (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide

(3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide (PubChem CID 160595542) has the molecular formula C55H95N11O10 and a molecular weight of 1070.43 g/mol. Its IUPAC name is (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide.

Molecular Properties

Compound Name(3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide
PubChem CID160595542
Molecular FormulaC55H95N11O10
Molecular Weight1070.43 g/mol
Exact Mass1069.73
IUPAC Name(3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide
SMILESCCCCCCC[C@@H](O)CC(=O)N[C@H](CCN)C(=O)C[C@H]1CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)CC(=O)[C@H](CCCCN)NC1=O
InChIInChI=1S/C55H95N11O10/c1-6-7-8-9-13-18-40(67)34-49(70)61-42(20-25-57)47(68)32-38-23-28-60-52(73)45(29-35(2)3)66-54(75)44(22-27-59)63-53(74)43(21-26-58)64-55(76)46(30-36(4)5)65-51(72)39(31-37-16-11-10-12-17-37)33-48(69)41(62-50(38)71)19-14-15-24-56/h10-12,16-17,35-36,38-46,67H,6-9,13-15,18-34,56-59H2,1-5H3,(H,60,73)(H,61,70)(H,62,71)(H,63,74)(H,64,76)(H,65,72)(H,66,75)/t38-,39+,40-,41+,42-,43+,44+,45+,46+/m1/s1
InChIKeyRDOSPIXDRZEZDQ-SYMXYNERSA-N
XLogP1.19
TPSA362.15 Ų
H-Bond Donors12
H-Bond Acceptors14
Rotatable Bonds28
Heavy Atoms76
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001070.43
LogP ≤ 51.19
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide?
The IUPAC name of (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide (CID 160595542) is (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide.
What is the SMILES notation for (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide?
The canonical SMILES for (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide is CCCCCCC[C@@H](O)CC(=O)N[C@H](CCN)C(=O)C[C@H]1CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)CC(=O)[C@H](CCCCN)NC1=O.
What is the InChIKey of (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide?
The InChIKey is RDOSPIXDRZEZDQ-SYMXYNERSA-N. The full InChI is InChI=1S/C55H95N11O10/c1-6-7-8-9-13-18-40(67)34-49(70)61-42(20-25-57)47(68)32-38-23-28-60-52(73)45(29-35(2)3)66-54(75)44(22-27-59)63-53(74)43(21-26-58)64-55(76)46(30-36(4)5)65-51(72)39(31-37-16-11-10-12-17-37)33-48(69)41(62-50(38)71)19-14-15-24-56/h10-12,16-17,35-36,38-46,67H,6-9,13-15,18-34,56-59H2,1-5H3,(H,60,73)(H,61,70)(H,62,71)(H,63,74)(H,64,76)(H,65,72)(H,66,75)/t38-,39+,40-,41+,42-,43+,44+,45+,46+/m1/s1.
What are the key properties of (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide?
(3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide has a molecular weight of 1070.43 g/mol, XLogP of 1.19, 28 rotatable bonds, 12 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-N-[(3R)-5-amino-1-[(2S,5S,8S,11S,16R,19S,22S)-19-(4-aminobutyl)-5,8-bis(2-aminoethyl)-22-benzyl-2,11-bis(2-methylpropyl)-3,6,9,12,17,20,23-heptaoxo-1,4,7,10,13,18-hexazacyclotricos-16-yl]-2-oxopentan-3-yl]-3-hydroxydecanamide is sourced from PubChem (CID 160595542), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).